Skip to main content
. Author manuscript; available in PMC: 2014 Jun 5.
Published in final edited form as: J Heart Lung Transplant. 2010 Apr 9;29(7):731–738. doi: 10.1016/j.healun.2010.02.007

Table 5.

AUC of the LAS post-transplant model to predict 1-year survival and the AUC and the parameters of LAS post-transplant model to predict 5-year survival

LAS model
& 1- year survival		 LAS variables
& 5-year survival
Area under the curve 0.580 0.566
Variables B coefficient1 B coefficient
Recipient age 0.00351 0.00955***
Creatinine 0.0620 0.129***
NYHA Class −0.489 −0.364***
FVC −0.00275 −0.0000766
PCW 0.0330 −0.0197
Mechanical Ventilation 0.313 0.681***
Diagnosis Group2
B 0.623 0.0991
C 0.00851 0.0911
D 0.413 0.174
Diagnosis detailed
Bronchiectasis 0.0561 0.0297
Eisenmenger’ s 0.394 0.583**
LAM −0.624 −0.619**
Obstructive Bronchiolitis −0.444 −0.153
Pulmonary Fibrosis other 0.172 0.344***
Sarcoid PA mean>30 −0.122 0.157
Sarcoid PA mean<30 −0.0165 0.135
*

p < .05,

**

p < .01,

***

p < .001

1

B coefficient derived in the LAS post-transplant model. P-values are N/A.

2
Diagnosis groups are defined as:
  • Group A = Obstructive lung disease (e.g., emphysema)
  • Group B = Pulmonary vascular disease (e.g., primary pulmonary hypertension)
  • Group C = Cystic fibrosis or immunodeficiency disorder
  • Group D = Restrictive lung disease (e.g. IPF, NSIP, sarcoidosis)